Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a Unit of H.C Wainwright, in a $10.5 Million Public Offering of Medical Transcript Billing, Corp.
Press Release – New York, NY – April 11, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (NASDAQ: MTBC).
MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions. MTBC received approximately $10.5 million in gross proceeds from the sale of 420,000 shares of Series A Preferred Stock sold to the public at a price of $25 per share for an aggregate offering amount of $10.5 Million. The series A Preferred Stock is traded on NASDAQ under the symbol “MTBCA.” The offering is expected to close on or around April 6, 2018, subject to the satisfaction of customary closing conditions.
The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia, Tom Rose and Jay Yamamoto.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
- Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
- Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019